Sort
82,697 grants matching “vaccine development”
THE IMPACTA PERU CLINICAL TRIALS UNIT
$2,376,608Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2012 · AI
SPORE in Soft Tissue Sarcoma
$2,375,406Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory
$2,375,210Anthony Griffiths · University Of Missouri-Columbia · UC7 · FY2024 · AI
CD4 T cells in anti-viral immunity and immune pathology
$2,375,202Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · U19 · FY2015 · AI
CD4 T cells in anti-viral immunity and immune pathology
$2,375,202Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · U19 · FY2017 · AI
CD4 T cells in anti-viral immunity and immune pathology
$2,375,202Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · U19 · FY2018 · AI
CD4 T cells in anti-viral immunity and immune pathology
$2,375,202Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · U19 · FY2016 · AI
SPORE in Gastrointestinal Cancers
$2,375,000Alison P Klein · Johns Hopkins University · P50 · FY2020 · CA
Center for the Study of Immune Mechanisms of Flavivirus Control
$2,374,326Michael J Gale · University Of Washington · U19 · FY2014 · AI
Optical Technologies and Molecular Imaging for Cervical Neoplasia
$2,374,167Michele Follen · Texas Tech University Health Scis Center · P01 · FY2013 · CA
COVID-19 Clinical Support and Research
$2,371,299Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Caribbean Primate Research Center Program
$2,371,237Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2021 · OD
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
$2,371,101Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Immuno-Prophylaxis-Therapy &Diagnosis of Tularemia
$2,370,307Boston Medical Center · U19 · FY2004 · AI
The UCSD CD4 Collaborative Clinical Trial Unit
$2,370,023Constance Ann Benson · University Of California, San Diego · UM1 · FY2017 · AI
Sample Collection and General Screening Protocols
$2,369,376Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
General Clinical Research Center
$2,368,789E Albert Reece · University Of Maryland Baltimore · M01 · FY2008 · RR
General Clinical Research Center
$2,368,789E Albert Reece · University Of Maryland Baltimore · M01 · FY2009 · RR
CD4 T cells in anti-viral immunity and immune pathology
$2,368,478Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · U19 · FY2014 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$2,368,328Ronald Brown · Quality Biological, Inc. · N01 · FY2011 · AI
HIV/AIDS Vaccine Development
$2,367,571Gary J Nabel · Niaid Extramural Activities · Z01 · FY2007 · AI
Development of synthetic viral circuitry to regulate viruses in mosquito disease vectors
$2,367,250Omar Sultan Akbari · University Of California, San Diego · DP2 · FY2019 · AI
Core B: Data Management Core
$2,366,861J. Philip Miller · Washington University · U19 · FY2024 · AI
Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)
$2,366,785Anne Searls De Groot · University Of Rhode Island · U19 · FY2013 · AI
Virus-induced Cell Fate Decisions in Anti-Viral Immunity
$2,366,504Troy D Randall · University Of Alabama At Birmingham · U19 · FY2016 · AI